This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.
During the last few months, the Illinois Department of Public Health (IDPH), in conjunction with the Medical Cannabis Advisory Board (MCAB), voted to add four new recommended conditions to list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.
NORML Announces Plans for 2019 Conference and Lobby Day. “Adding a condition for which a physician could recommend medical marijuana instead of an opioid is a safer pain management tool that will be useful for both our doctors and patients.” Cameron Pinkerton, Event Coordinator, DFW NORML.
In Congress this week Senator Cory Booker (D-NJ), along with Representatives Barbara Lee (D-CA) and Ro Khanna (D-CA), introduced The Marijuana Justice Act of 2019, to remove marijuana from the Controlled Substances Act and incentivize states to end the racially disparate criminalization of marijuana consumers. CO resident? GA resident?
HB 1365 (authored by Rep Lucio, III) and SB90 (authored by Sen Menendez) would allow patients with debilitating conditions access to medical cannabis to therapeutically treat the symptoms of their condition. View pictures from the event! Ask your legislators to coauthor HB 1365 and SB 90 now! Stay tuned to watch the hearing.
The authors report a substantial clinical improvement in attention, visual processing, visuomotor speed, working memory, and other parameters beginning by day seven, with no adverse events or side effects. 2019, doi:10.1177/2045125319881916 Rebelos, Eleni et al. Frontiers in pharmacology vol. 2016, doi:10.3389/fphar.2016.00422
Senator Glen Sturtevant’s (R-10) SB1632 seeks to allow medical cannabis administration on school property and at school events. Virginia students and their families depend on new, safely produced and regulated cannabidiol and THCA oils to treat a host of potentially debilitating conditions. Marijuana policy should be evidence based.
Mississippi voters will receive the opportunity to vote this November on whether or not to allow medical marijuana for patients with debilitating medical conditions. Update : SB 420 was scheduled for Health, Human Services and Elderly Affairs Committee work session and a decision making this week, but both events were cancelled.
Part I of this series detailed the difficult, time consuming, and courageous work behind the process of how the Illinois Department of Public Health (IDPH) added female orgasmic disorder to the list of qualifying debilitating condition for medical patients in the Compassionate Use of Medical Cannabis Program.
And officials in San Francisco, California are considering a proposal to allow marijuana to be socially consumed and sold at temporary events. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. Your Highness, Carly. Actions to Take. CA resident?
Post-traumatic stress disorder (PTSD) is a condition most often associated with military veterans, but it is not confined to wartime experiences. Most recently, a study released in the fall of 2019 reveals some of the specific ways in which compounds within marijuana work to block fear-related memories.
The sixth annual CannX is the first in-person event since 2019. We look forward to welcoming you in-person to CannX 2022 – for what is sure to be an outstanding event!” “We are very much excited to announce that CannX 2022 will be held in-person,” said Yossi Bornstein, event organizer. Related Stories.
For those engaged in the legal cannabis industry in Oregon, the 2019 Oregon Legislative Session is of the utmost importance and relevance. . HB 2233 is nearly identical to SB 639, however it only provides for the regulation of temporary events and cannabis lounges. SB 639 AND HB 2233.
Pritzker signed into law the Cannabis Regulation and Tax Act on June 25, 2019, Edibles price per gram has steadily increased and peaked at $27.16 April 2019 to peak of $40.28 On June 25, 2019, Gov. To find cannabis-friendly events in Illinois, visit here. Shortly after Gov. January 2020, the first month of legalization.
Pritzker signed into law the Cannabis Regulation and Tax Act on June 25, 2019, and cultivators ramped up production for adult-use sales. in August 2019, the highest since fall of 2016. On June 25, 2019, Gov. To find cannabis-friendly events in Illinois, visit here. Price per gram jumped to $75.12 in March 2020.
On June 25, 2019, Gov. On June 25, 2019, Gov. August 12, 2019, Illinois expanded the medical cannabis program to include an additional 11 conditions and changed the Act from a pilot program to a permanent program. To find cannabis-friendly events in Illinois, visit here. per gram.
The condition, known as “long COVID” — with patients often referred to as “COVID long haulers” — is typified by a series of symptoms that linger long after someone has recovered from COVID-19, even months after they no longer test positive for the novel coronavirus. Cannabis and coping with the pandemic. The Cannigma / Anthony Travagliante).
If you are considering medical marijuana for pain management, it’s essential to know which conditions it can ease. Continue reading as we list the top common pain conditions that medical marijuana is proven to help patients. Migraines and headaches can be debilitating and severe conditions. Migraines and Headaches.
If you are considering medical marijuana for pain management, it’s essential to know which conditions it can ease. Continue reading as we list the top common pain conditions that medical marijuana is proven to help patients. Migraines and headaches can be debilitating and severe conditions. Migraines and Headaches.
In Canada today, close to 70% of all those surveyed aged 19+ believe that cannabis is an alternate form of treatment to some medical conditions according to Vividata’s Vivintel , the nation’s largest syndicated cannabis consumer study. We are partnering with Canopy Growth to offer a unique event of fun and canna-learning.
If you are considering medical marijuana for pain management, it’s essential to know which conditions it can ease. Continue reading as we list the top common pain conditions that medical marijuana is proven to help patients. Migraines and headaches can be debilitating and severe conditions. Migraines and Headaches.
Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.
Natural sunlight may be tricky to control in certain climates, but South Africa is blessed with near perfect conditions for cannabis. We will be landing in Cape Town this November, and in anticipation of our South African sizzling summer event, we’re talking SUN. CannaTech is coming to Cape Town November 2019.
— Second quarter 2019 revenue of $12.7 Adjusted EBITDA for the second quarter 2019 totaled $2.5 Company issues 2019 guidance of $55 -57 million of revenue and positive Adjusted EBITDA. 30, 2019 /PRNewswire/ – Harborside Inc. 30, 2019 /PRNewswire/ – Harborside Inc. 2019 Guidance. Financial Highlights.
16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Event details below: Date: Tuesday, September 17th 2019. MONTREAL and SMITHS FALLS, ON, Sept. Time: 9:00AM to 5:00PM.
In 2019, the island’s economy grew by 2.1% Should any such risk factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. in real terms to £4.97
The charges are the culmination of a nearly two-year joint investigation by the Ontario Securities Commission (OSC) and Royal Canadian Mounted Police (RCMP) after a whistleblower alerted Canada’s cannabis regulator in July 2019 to five unlicensed cultivation rooms the company had been operating since late 2018.
CBD continues to flourish in the markets despite lack of federal regulations, and we’ve identified some significant events that indicate there’s no sign it’s stopping. Yet despite this momentous event, it must be noted that the only FDA-approved CBD drug product available is Epidiolex. CBD Class Action Litigation.
11, 2019 /PRNewswire/ – Aurora Cannabis Inc. the “ Company ” or “ Aurora “) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today its financial and operational results for the fourth quarter and fiscal year ended June 30, 2019. million in Q3 2019.
In testimony before the US Senate in July 2019, Dr. Amy Abernethy, Principal Deputy Commissioner at FDA, stated that the Agency recognizes the need for “regulatory clarity, particularly given the significant public interest in hemp products, and CBD in particular.” Who’s responsible for regulating CBD in pet products?
In practical terms, we studied how pharmaceuticals interact, how to accurately measure and dispense medications, advise patients on effective protocols and adverse events, what to do and not to do when using specific medications. In 2019, I completed the Israel Ministry of Health’s cannabis curriculum for pharmacists.
CannMed: For what conditions do you think CBG has the most promise? Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin. It can be a very difficult condition. So, there’s a lot of interest in CBG, which is really exciting.
In addition to three social equity adult use cannabis dispensaries that opened in 2022, 189 other conditional licensees are in the process of receiving full dispensary license from IDFPR. To learn about cannabis-friendly events in Illinois, visit here. These figures do not include taxes collected.
The closing of the transaction will be subject to customary closing conditions, including due diligence to the satisfaction of both parties and the entering into of definitive agreements. per share (the “Flora Share Price”). In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing.
Sep 17, 2019 | 2019 , Press Releases |. 17, 2019 /CNW/ – CannTrust Holdings Inc. The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information or statements. CannTrust Discloses Notice of Licence Suspension.
The New Mexico Department of Health (NMDOH) filed an emergency rule on March 1, 2019, temporarily raising the medical cannabis plant count limit to 2,500 plants per producer. NMAC-2019-MCP-7.34.4.8. NMAC Rule Change – 2019 – MCP – Emergency Amendment. Upcoming Events. Here’s the full document.
For specific conditions, cannabis prescriptions will become the purview of physicians and not require special dispensation from the Ministry of Health. Israeli medical cannabis patients protesting outside of CannaTech Tel Aviv 2019 (photo by Ilyan Marshak). Ofir and Erez are medical cannabis patients and advocates.
In 2019, in what seems like a lifetime ago, I purchased my first legal gummies during an annual writers’ conference in Portland. Thirty years of conditioning is difficult to break. To learn more about cannabis-friendly events in Illinois, visit here. For more Illinois News Joint reviews, visit here.
However, in 2019, Ecuador’s Constitutional Court decriminalized the possession of small amounts of weed for personal use. In 2019, Ecuador’s National Assembly passed a resolution that called for the creation of a commission to study the use of cannabis-based medicines to treat a range of medical conditions.
Dec 19, 2019, 17:00 ET. At this stage we don’t know why they just don’t give it up and go and do something else. The press release. . NEWS PROVIDED BY. CannTrust Holdings Inc. . SHARE THIS ARTICLE. . VAUGHAN, ON , Dec. NYSE Listing Update.
9-THC, the main psychoactive component in cannabis, rose from about 4 per cent to 16 per cent in the United States over the period 1995–2019, and from about 6 per cent to 11 per cent in Europe over the period 2002–2019. ?9-THC The measures could work in a way similar to the provisions of the WHO Framework Convention on Tobacco Control.
On June 27, 2019, Acreage implemented an arrangement under section 288 of the Business Corporations ?Act satisfaction or waiver of certain closing conditions, acquire ?all occurrence or waiver of the Triggering Event, subject to a minimum price of US$6.41 seamless, consumer-focused, branded experience. per Floating Share.
Horvath has served as CEO of the Company since January 2019 and as a member of the Company’s Board of Directors since July 2018. Mr. Whitaker has served as the Company’s Chief Operating Officer since February 2019. The vacancy on the Company’s Board of Directors will be filled in due course.
The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. However, unlike a conventional new generic drug, cannabis use is not restricted to a single or limited set of conditions.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content